From: Consistency and precision of cancer reporting in a multiwave national panel survey
 | Model 1 | Model 2 | Model 3 | |||
---|---|---|---|---|---|---|
Year of birth | 0.98*** | 0.97,0.99 | 0.98*** | 0.97,0.99 | 0.98** | 0.97,1.00 |
Female | 1.34* | 0.95,1.89 | 1.31 | 0.93,1.86 | 1.15 | 0.64,2.07 |
Nonwhite | 1.62** | 1.10,2.39 | 1.75*** | 1.18,2.61 | 1.47 | 0.91,2.38 |
Not married | 0.80 | 0.57,1.12 | 0.90 | 0.62,1.31 | 0.71 | 0.43,1.16 |
Education | 0.94* | 0.88,1.00 | 0.94* | 0.88,1.01 | 0.90** | 0.83,0.98 |
Rural | 1.29 | 0.80,2.07 | 1.35 | 0.83,2.20 | 1.67* | 0.93,2.97 |
Midwest (NE = ref.) | 0.85 | 0.52,1.38 | 0.89 | 0.54,1.45 | 0.74 | 0.41,1.34 |
South | 0.72 | 0.45,1.15 | 0.81 | 0.50,1.32 | 0.85 | 0.48,1.52 |
West | 0.66 | 0.39,1.12 | 0.77 | 0.45,1.31 | 0.74 | 0.39,1.39 |
Inconsistent reports | Â | Â | 2.42*** | 1.59,3.69 | 2.72*** | 1.46,5.10 |
Number of reports | Â | Â | 2.20*** | 1.76,2.75 | 1.91*** | 1.44,2.53 |
Respondent (self = ref.) | Â | Â | Â | Â | Â | Â |
   Only proxy |  |  | 1.87*** | 1.21,2.90 | 1.74** | 1.03,2.93 |
   Self and proxy |  |  | 2.07*** | 1.38,3.09 | 1.79** | 1.07,2.99 |
Diagnosis year | Â | Â | Â | Â | 0.94*** | 0.91,0.97 |
Cancer site (Breast = ref.) | Â | Â | Â | Â | Â | Â |
   Colon |  |  |  |  | 1.91 | 0.86,4.26 |
   Lung |  |  |  |  | 1.46 | 0.42,5.00 |
   Lymphoma |  |  |  |  | 0.78 | 0.26,2.39 |
   Melanoma |  |  |  |  | 1.84 | 0.63,5.38 |
   Prostate |  |  |  |  | 1.80 | 0.77,4.19 |
   Skin |  |  |  |  | 0.76 | 0.12,4.92 |
   Uterine |  |  |  |  | 1.78 | 0.72,4.37 |
   Ovarian |  |  |  |  | 1.50 | 0.39,5.82 |
   Cervical |  |  |  |  | 2.38** | 1.02,5.58 |
   Other |  |  |  |  | 1.49 | 0.79,2.81 |
Limitations | Â | Â | Â | Â | 1.34 | 0.87,2.07 |
N | 504 | 504 | 384 |